DiscoverJAMA Neurology Author InterviewsFremanezumab for the Treatment of Migraine and Major Depressive Disorder
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Update: 2025-05-05
Share

Description

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder